Jane Street’s Asensus Surgical, Inc. ASXC Stock Holding History

Jane Street’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,200	Closed	-$8K	–	11192
2022 Q1	$8K	Sell	12,200 -210,800	-95%	-$162K	﹤0.01%	10099
2021 Q4	$248K	Sell	223,000 -105,400	-32%	-$163K	﹤0.01%	8491
2021 Q3	$608K	Sell	328,400 -399,900	-55%	-$898K	﹤0.01%	6907
2021 Q2	$2.31M	Buy	728,300 +220,600	+43%	+$551K	﹤0.01%	4042
2021 Q1	$1.65M	Buy	+507,700	New	+$1.84M	﹤0.01%	4401
2018 Q4	–	Sell	-1,462	Closed	-$110K	–	5902
2018 Q3	$110K	Buy	1,462 +470	+47%	+$31.8K	﹤0.01%	4840
2018 Q2	$56K	Buy	+992	New	+$36.1K	﹤0.01%	4804
2016 Q2	–	Sell	-5,877	Closed	-$325K	–	4712
2016 Q1	$325K	Buy	+5,877	New	+$252K	﹤0.01%	3111

Other funds holding ASXC

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jane Street's ASXC Position: Q3 2024 in Review

Jane Street sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 489,252 shares — an estimated $163K sold.

Jane Street first reported a position in ASXC in Q3 2017 and held it in 20 quarters. The position peaked at $1.42M in Q1 2021. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

Jane Street reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
Jane Street sold 489,252 Asensus Surgical, Inc. shares in Q3 2024, an estimated $163K.
Jane Street first reported a position in Asensus Surgical, Inc. in Q3 2017 and held it in 20 quarters.
Jane Street's Asensus Surgical, Inc. position peaked at $1.42M in Q1 2021.
1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.